Persperion Diagnostics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Persperion Diagnostics Inc. - overview
Established
2022
Location
San Diego, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2022 by CEO Lu Yin, Persperion Diagnostics Inc. , a. k. a.
Persperion Diagnostics operates as a developer of a healthcare platform specializing in the development of non-invasive touch-based sweat-sensing technology for in-vitro diagnostic medical devices. In November 2023, Persperion Diagnostics Inc. raised USD 4 million in seed funding. The company provides a touch-based, non-invasive sweat biosensing solution for personal health management.
Persperion Diagnostics offers test strips that measure these biomarkers, including metabolites, electrolytes, hormones, drugs, and beyond. Persperion Diagnostics plans to use its proceeds from November 2023 funding to support its product commercialization.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.persperiontech.com
Verticals
HealthTech, Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.